Business Context and Reporting Period
This Form 6-K filing by Check-Cap Ltd. (referred to as Mbody AI Ltd. in metadata) covers the period ending February 6, 2019. The filing reports on a registered direct offering of securities entered into on February 4, 2019, with an expected closing date of February 6, 2019.
Key Financial Metrics
The filing details a capital raise transaction rather than operational financial results. Key metrics include:
- Gross Proceeds: Approximately $7.5 million.
- Securities Issued: 1,881,500 units at $2.58 per unit and 1,024,876 pre-funded units at $2.57 per unit.
- Unit Composition: Each unit includes one ordinary share and one Series D Warrant to purchase 0.5 ordinary share. Each pre-funded unit includes one pre-funded warrant and one Series D Warrant.
- Warrant Terms: Series D Warrants have an exercise price of $2.58, are immediately exercisable, and expire on the fifth anniversary of issuance.
- Transaction Costs: Placement agent fees total 7% of gross proceeds plus a 1% management fee, a $30,000 expense allowance, and up to $110,000 in legal fee reimbursements.
The filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes
The primary material change is the execution of definitive agreements for the registered direct offering. The filing does not provide comparative financial data against prior periods to assess changes in operational performance.
Guidance, Outlook, and Risks
Management Commentary and Restrictions: The Purchase Agreement includes a 12-month lock-up period during which the Company cannot effect or enter into an agreement for a "variable rate transaction."
Placement Agent Compensation: H.C. Wainwright & Co., LLC serves as the exclusive placement agent. In addition to cash fees, the Company agreed to issue warrants to purchase up to 7% of the aggregate ordinary shares sold (approximately 203,446 shares). These Placement Agent Warrants have an exercise price of $3.225 (125% of the investor purchase price) and expire on February 4, 2024.
Risks and Contingencies: The closing of the offering is subject to the satisfaction of customary closing conditions. The filing incorporates by reference into various registration statements (Form S-8 and Form F-3).
Investor Verification Checklist
- Verify the actual closing date of the offering and confirmation of the $7.5 million gross proceeds.
- Confirm the total dilution impact from the issuance of 1,881,500 units, 1,024,876 pre-funded units, and 203,446 placement agent warrants.
- Review the full text of the Securities Purchase Agreement (Exhibit 10.1) for specific customary closing conditions.
- Assess the impact of the 12-month restriction on "variable rate transactions" on future capital raising strategies.